Australia · Health Care · AUD (Thousands) · Annual
Key financials
AUD|Thousands
ROE
-32.64%
2026 (actual)
ROA
-30.09%
2026 (actual)
Gross Margin
34.52%
2026 (actual)
Net Margin
-96.91%
2026 (actual)
Total Assets
A$38,457.00K
2026 (actual)
Net Income
-A$14,006.00K
2026 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
AUD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+87.2 pt
Company
ROA
-25.8 pt
Company
Gross Margin
-9.7 pt
Company
Sector average
Net Margin
-13.3 pt
Company
Total Assets
+11.9%
Company
Sector average (own scale)
Net Income
-66.4%
Company
Sector average
Detailed data
AUD|Thousands
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for GENETIC SIGNATURES LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.